— Stryker (NYSE: SYK) reported third-quarter 2019 earnings of $1.91 per share, vs. $1.90 per share expected.
— Total revenue grew 10.6% to $3.58 billion, in line with the street estimate. Organic sale grew 8.6% in Q3. Orthopaedics net sales of $1.3 billion increased 7.8% YoY.
— 2019 organic net sales growth expected near the higher end of the outlook range of 7.5% to 8.0%.
— Adjusted EPS for 2019 expected in the range of $8.20 to $8.25, and for the fourth quarter between $2.43 and $2.48.
— SYK shares have gained 43% since the beginning of this year.
Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a
PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the
With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,